Recommended purchasing channels for domestic authentic Apelvis-Piqray

Alpelisib (Alpelisib)-Piqray is a targeted therapy drug mainly used to treat hormone receptor-positive, human epidermal growth factor receptor 2-negative, PIK3CA-mutated advanced or metastatic breast cancer. Although it has been approved and widely used in the international market, Apelvis has not yet been officially launched in China, which makes domestic patients face certain purchasing difficulties.

Because Apelvis is not yet legally sold in the country, patients need to be particularly cautious when looking for ways to obtain the drug. First, some patients may consider purchasing through overseas channels, but this approach involves certain risks. The purchase of overseas drugs often involves complex legal and regulatory issues, and the source, quality and authenticity of the drugs are difficult to guarantee. In addition, importing drugs through personal channels may face customs inspection and the risk of being unable to clear customs smoothly, which brings unnecessary trouble to patients.

In China, due to policy and legal restrictions, the legality and safety of many drugs are very important. When patients seek Apelvis, they can consult medical institutions or doctors to find out whether there are feasible clinical trials. In some large hospitals or cancer research centers, there may be related research projects underway, and patients can obtain the drug or other new treatment options by participating in clinical trials. This not only helps patients obtain effective treatment opportunities, but also contributes to the development of new drugs.

In addition, patients can also pay attention to drug registration trends at home and abroad. Sometimes new foreign drugs will enter the Chinese market as soon as possible after being approved. Therefore, regularly understanding the launch progress of Apelvis in China will help patients grasp the information early and get the treatment they need in a timely manner.

Reference materials:https://www.piqray.com/